Cigna Corp (CI)
NYSE Market Open
The Cigna Group is a diversified health services company with major operations in pharmacy benefit management, specialty pharmacy, health insurance, and employer benefits. Its business is built around helping employers, health plans, government clients, and individuals manage healthcare access, cost, and pharmacy spending. The company’s scale increased significantly after its 2018 combination with Express Scripts, which made pharmacy benefit management a central part of its strategy.
Cigna’s PBM operations negotiate drug pricing and rebates, manage formularies, process pharmacy claims, and provide mail-order and specialty pharmacy services. These services are sold mainly to employers and health insurers, including large institutional clients. The company’s customer base includes major contracts such as work with the US Department of Defense, and it has also secured large commercial relationships with health insurers such as Centene. Specialty pharmacy is an important part of the model because complex and high-cost medicines account for a growing share of drug spending.
Alongside pharmacy services, Cigna provides medical insurance and related benefits, with a strong focus on employer-sponsored coverage. Many of its employer clients use self-funded arrangements, under which the employer bears medical cost risk while Cigna administers the plan and provides network access, claims management, care coordination, and other services. The company operates primarily in the United States and also serves international medical members. Its performance is influenced by healthcare utilization, prescription drug trends, regulation, employer demand, medical cost inflation, and scrutiny of PBM practices. Cigna’s distinguishing feature is the combination of benefits administration and pharmacy management within a broad health services platform.
Last updated
- Market Cap
- $76,600,648,226
- P/E
- 12.18
- P/FCF
- 10
- P/S
- 0.28
- Enterprise Value
- $100,460,648,226
- Sector
- Health Care
- Industry
- Health Care Services
- Address
- 900 COTTAGE GROVE ROAD, BLOOMFIELD, CT, 06002
The Real Risk Inside UnitedHealth Stock
Cigna Group (CI) Faces A Valuation Test, Is The Recent Pullback A Buying Opportunity?
Broader Market Settles Higher as Positive Inflation News Outweighs Chip Rout
Stocks Supported By Favorable Inflation News
Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev
Modern Therapy Group launches virtual intensive outpatient program for mental health
GILC Convenes World Leaders on Social Connection and Division During Global Loneliness Awareness Week
Dental Insurance Global Market Forecast 2026-2032: Plan Types, Customer Types, Distribution Channels, Coverage Levels, Regions, Technologies
Cummins Revenue Holds Up as Charges Weigh on Near-Term Earnings Clarity
Boom! FTC Squeezes Concessions from Cigna’s Express Scripts
Medicare Insurance Broker In Texas Safeguards Community Prospects
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $76,600,648,226
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $100,460,648,226
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 12.18
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.81
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.28
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 8.87
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.36
- EPS
- 23.77
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.11%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 10
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 8.69
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- $7,660,000,000
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 14.9%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 4.1%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.73
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.82
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.71
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.13
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $1,614,748
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 289.57
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 68.29B | 72.13B | 69.52B | 66.94B | 65.26B |
| Cost of revenue | 62.02B | 66.06B | 63.37B | 61.02B | 58.9B |
| Gross profit | 6.27B | 6.08B | 6.14B | 5.93B | 6.37B |
| Operating income | 2.16B | 2.01B | 2.35B | 2.07B | 1.73B |
| EBITDA | 2.81B | 2.73B | 3.04B | 2.75B | 2.41B |
| Net income | 1.65B | 1.23B | 1.87B | 1.53B | 1.32B |
| Income taxes | 409M | 543M | 322M | 389M | 239M |
| Interest expense | -357M | — | -347M | — | -362M |
| Other operating expenses | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 4.11B | 4.07B | 3.8B | 3.86B | 4.64B |
| Basic EPS | 6.3 | 4.68 | 7.02 | 5.76 | 4.88 |
| Diluted EPS | 6.26 | 4.66 | 6.98 | 5.71 | 4.85 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 153.27B | 157.92B | 157.92B | 151.65B | 150.66B |
| Total liabilities | 110.82B | 116.05B | 115.91B | 111.22B | 110.24B |
| Total equity | 42.44B | 41.87B | 42.01B | 40.43B | 40.41B |
| Cash & equivalents | 7.04B | 7.68B | 6.03B | 4.33B | 8.33B |
| Current assets | 43.03B | 47.81B | 46.74B | 44.72B | 43.56B |
| Current liabilities | 52.61B | 56.34B | 56.45B | 56.78B | 55.75B |
| Accounts payable | 9.88B | 10.66B | 9.35B | 9.94B | 9.14B |
| Receivables | 26.61B | 28.77B | 31.71B | 31.15B | 26.93B |
| Inventories | 5.83B | 7.34B | 5.63B | 5.97B | 5.18B |
| Goodwill | 45.53B | 44.92B | 44.92B | 44.38B | 44.37B |
| Long-term debt | 29.37B | 30.87B | 30.95B | 26.48B | 26.46B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 1.13B | 6.15B | 3.42B | -1.89B | 1.92B |
| Investing cash flow | -637M | -420M | -4.39B | -797M | 1.2B |
| Financing cash flow | -1.14B | -4.07B | 2.66B | -1.33B | -3.68B |
| Change in cash | -656M | 1.67B | 1.69B | -3.99B | -555M |
| Net income | 1.86B | 1.27B | 1.97B | 1.63B | 1.41B |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 3 — Cigna Group | View Filing | |
| edgar index | 3 — Cigna Group | View Filing | |
| edgar index | 3 — Cigna Group | View Filing | |
| edgar index | 3 — Cigna Group | View Filing | |
| edgar index | 3 — Cigna Group | View Filing | |
| form 3 | Form 3 — Perlberg Matthew | View Filing | |
| form 3 | Form 3 — Perlberg Matthew | View Filing | |
| form 3 | Form 3 — Perlberg Matthew | View Filing | |
| form 3 | Form 3 — Perlberg Matthew | View Filing | |
| form 3 | Form 3 — Perlberg Matthew | View Filing | |
| form 3 | Form 3 — Perlberg Matthew | View Filing | |
| form 3 | Form 3 — Sanford Paul A | View Filing | |
| form 3 | Form 3 — Sadler Jason D | View Filing | |
| form 3 | Form 3 — Sadler Jason D | View Filing | |
| form 3 | Form 3 — Sadler Jason D | View Filing | |
| form 3 | Form 3 — Sadler Jason D | View Filing | |
| form 3 | Form 3 — Sadler Jason D | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Kautzner Adam | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| form 3 | Form 3 — Holgerson Bryan | View Filing | |
| edgar index | 11-K — Cigna Group | View Filing | |
| edgar index | 4 — Cigna Group | View Filing | |
| edgar index | 144 — Cigna Group | View Filing | |
| form 4 | Form 4 — Kates Jamie G | View Filing | |
| form 4 | Form 4 — Kates Jamie G | View Filing | |
| form 4 | Form 4 — Kates Jamie G | View Filing | |
| edgar index | 4 — Cigna Group | View Filing | |
| edgar index | 4 — Cigna Group | View Filing | |
| form 4 | Form 4 — Koka Durga Prasad | View Filing | |
| form 4 | Form 4 — Kurian George | View Filing | |
| edgar index | 4 — Cigna Group | View Filing | |
| edgar index | 8-K — Cigna Group | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| edgar index | 144 — Cigna Group | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing | |
| form 4 | Form 4 — Cordani David | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free